Covington Advises Financial Advisor to Advanced Accelerator Applications in $3.9 Billion Sale

Covington Advises Financial Advisor to Advanced Accelerator Applications in $3.9 Billion Sale

November 3, 2017

NEW YORK—Covington represented Jefferies LLC as exclusive financial advisor to Advanced Accelerator Applications S.A. (AAAP) in its $3.9 billion all cash sale to Novartis AG.

Based in Saint-Genis-Pouilly, France, AAAP is a radiopharmaceutical company developing, producing, and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy.

The Covington team for the transaction includes David Schwartzbaum, Becky Hurt, and John Mei.